218 related articles for article (PubMed ID: 28651547)
1. Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies?
Pott MC; Frede N; Wanders J; Hammarström L; Glocker EO; Glocker C; Tahami F; Grimbacher B
BMC Immunol; 2017 Jun; 18(1):34. PubMed ID: 28651547
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
[TBL] [Abstract][Full Text] [Related]
3. BAFF, APRIL and human B cell disorders.
Tangye SG; Bryant VL; Cuss AK; Good KL
Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
[TBL] [Abstract][Full Text] [Related]
4. Role of apoptosis in common variable immunodeficiency and selective immunoglobulin A deficiency.
Yazdani R; Fatholahi M; Ganjalikhani-Hakemi M; Abolhassani H; Azizi G; Hamid KM; Rezaei N; Aghamohammadi A
Mol Immunol; 2016 Mar; 71():1-9. PubMed ID: 26795881
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL.
Le Pottier L; Sapir T; Bendaoud B; Youinou P; Shoenfeld Y; Pers JO
Ann N Y Acad Sci; 2007 Sep; 1110():426-32. PubMed ID: 17911457
[TBL] [Abstract][Full Text] [Related]
6. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
Baert L; Manfroi B; Casez O; Sturm N; Huard B
J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081
[TBL] [Abstract][Full Text] [Related]
7. Mapping of Signaling Pathways Linked to sIgAD Reveals Impaired IL-21 Driven STAT3 B-Cell Activation.
Lemarquis AL; Theodors F; Einarsdottir HK; Ludviksson BR
Front Immunol; 2019; 10():403. PubMed ID: 30936864
[No Abstract] [Full Text] [Related]
8. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
Eilertsen GØ; Nossent JC
Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
[TBL] [Abstract][Full Text] [Related]
10. [Cytokines in children with immunodeficiencies].
Kowalczyk D
Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
[TBL] [Abstract][Full Text] [Related]
11. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies.
Blanco E; Pérez-Andrés M; Arriba-Méndez S; Serrano C; Criado I; Del Pino-Molina L; Silva S; Madruga I; Bakardjieva M; Martins C; Serra-Caetano A; Romero A; Contreras-Sanfeliciano T; Bonroy C; Sala F; Martín A; Bastida JM; Lorente F; Prieto C; Dávila I; Marcos M; Kalina T; Vlkova M; Chovancova Z; Cordeiro AI; Philippé J; Haerynck F; López-Granados E; Sousa AE; van der Burg M; van Dongen JJM; Orfao A;
J Allergy Clin Immunol; 2019 Sep; 144(3):809-824. PubMed ID: 30826363
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune disease in primary antibody deficiencies].
Sarmiento E; Mora R; Rodríguez-Mahou M; Rodríguez-Molina J; Fernández-Cruz E; Carbone J
Allergol Immunopathol (Madr); 2005; 33(2):69-73. PubMed ID: 15808112
[TBL] [Abstract][Full Text] [Related]
13. BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies.
López De Padilla CM; McNallan KT; Crowson CS; Bilgic H; Bram RJ; Hein MS; Ytterberg SR; Amin S; Peterson EJ; Baechler EC; Reed AM
J Rheumatol; 2013 Mar; 40(3):294-302. PubMed ID: 23322463
[TBL] [Abstract][Full Text] [Related]
14. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
[TBL] [Abstract][Full Text] [Related]
15. B-cell-activating factor, a proliferation inducing ligand and co-stimulatory molecules in the pathogenesis of immune thrombocytopenia in childhood.
Gözmen S; Karapnar TH; Tüfekçi Ö; Vergin C; Yüksel F; İrken G; Ören H
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):494-9. PubMed ID: 24911453
[TBL] [Abstract][Full Text] [Related]
16. 'That Obscure Object of Desire': in systemic lupus erythematosus B-cell activating factor/B-lymphocyte stimulator is targeted both by the immune system and by physicians.
Sanchez-Niño MD; Ortiz A
Nephrol Dial Transplant; 2015 Mar; 30(3):394-400. PubMed ID: 24914092
[TBL] [Abstract][Full Text] [Related]
17. Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease.
Xin G; Cui Z; Su Y; Xu LX; Zhao MH; Li KS
Nephrology (Carlton); 2013 Mar; 18(3):209-14. PubMed ID: 23317407
[TBL] [Abstract][Full Text] [Related]
18. Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NFκB and ERK.
Badr G; Sayed A; Abdel-Maksoud MA; Mohamed AO; El-Amir A; Abdel-Ghaffar FA; Al-Quraishy S; Mahmoud MH
PLoS One; 2015; 10(4):e0125340. PubMed ID: 25909640
[TBL] [Abstract][Full Text] [Related]
19. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.
Mackay F; Silveira PA; Brink R
Curr Opin Immunol; 2007 Jun; 19(3):327-36. PubMed ID: 17433868
[TBL] [Abstract][Full Text] [Related]
20. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.
Haselmayer P; Vigolo M; Nys J; Schneider P; Hess H
Eur J Immunol; 2017 Jun; 47(6):1075-1085. PubMed ID: 28383107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
